Alteogen Receives USD 20 Million Upfront Payment from Daiichi Sankyo
Alteogen announced that it has received an upfront payment of USD 20 million (approximately KRW 28 billion) from…
Daiichi Sankyo
2 개의 기사가 있습니다.
Alteogen Signs USD 280 Million Licensing Agreement with Daiichi Sankyo
Alteogen is advancing in the development of the world’s first subcutaneous (SC) injection for antibody-drug conjugates (ADCs). On…